New Podcast Episode by PharmaSources!

[Pharma Sources]

View this E-mail (https://info.cphi-chinaedm.com/x/?S7Y1Mf2fa2tsYGJq8D.H1tTA3Nzwf5GthaGxsZkBAAA67)  (https://info.cphi-chinaedm.com/x/?S7Y1Mf2fa2tsYGJq8D.H1tTA3Nzwf5GthaGxsZkBAAA67)online

 (https://www.pharmasources.com/pharmavibe/?utm_source=EDM&utm_medium=online&am p;utm_campaign=enedmpodcast0413)
WELCOME TO
PharmaVibe
Podcast hosted by PharmaSources

Listen and sense the heartbeat of the industry through news stories, key conferences, and in-depth interviews encompassing an array of specialties, sectors, and areas.
Subscribe Now (https://www.pharmasources.com/pharmavibe/?utm_source=EDM&utm_medium=online&am p;utm_campaign=enedmpodcast0413)
 (https://www.pharmasources.com/pharmavibe/?utm_source=EDM&utm_medium=online&am p;utm_campaign=enedmpodcast0413)
Latest Release
 

 

EPISODE 11 | 11 MIN | 13 April 2022
#Drug Review   #R&D   #Business
Weekly Pharma News Review 
(Mar.31-Apr.08)
The release of phase III clinical data for treating outpatients infected with mild and moderate COVID-19 with Kintor Pharmaceuticals' proxalutamide sparked an intense interest this week.

The pharma news review in this episode covers a total of 18 pieces of news in 3 sections, including drug review, R&D, and business.
Play (https://www.pharmasources.com/pharmavibe/detail/11.html/?utm_source=EDM&utm_medium=online&am p;utm_campaign=enedmpodcast0413)

 

Featured Episode
 

EPISODE 10 | 12 MIN | 07 Apr. 2022
#Drug Review  #Business  #R&D  #Listing
Weekly News Review (Mar.28-Apr.1)
Play (https://www.pharmasources.com/pharmavibe/detail/10.html/?utm_source=EDM&utm_medium=online&am p;utm_campaign=enedmpodcast0413)

EPISODE 9 | 9 MIN | 30 Mar 2022
#Drug Review  #COVID-19  #R&D  #Business
Weekly News Review (Mar.21-Mar.25)
Play (https://www.pharmasources.com/pharmavibe/detail/9.html/?utm_source=EDM&utm_medium=online&am p;utm_campaign=enedmpodcast0413)

 (https://efile.imsinoexpo.com/efile/CPhI/Yingqi/PharmaSources%20Sponsorship%20Package%20final.pdf?utm_source=EDM&utm_medium=online&am%20p;utm_campaign=enedmpodcast0413)
 (https://www.facebook.com/Pharmasources/?utm_source=EDM&utm_medium=online&am p;utm_campaign=enedmpodcast0413) (https://twitter.com/Pharmachina365/?utm_source=EDM&utm_medium=online&am p;utm_campaign=enedmpodcast0413) (https://www.linkedin.com/company/13436110/admin/?utm_source=EDM&utm_medium=online&am p;utm_campaign=enedmpodcast0413)
 (https://www.pharmasources.com/?utm_source=EDM&utm_medium=online&am p;utm_campaign=enedmpodcast0413)Contact us
PharmaSources at imsinoexpo.com (mailto:PharmaSources at imsinoexpo.com)

If you no longer wish to receive our e-mail updates,
please go here to unsubscribe. (https://info.cphi-chinaedm.com/x/plugin/?pName=unsubscribe&MIDRID=S7Y1Mf2fa2tsYGJq8D.H1tTA3Nzwf5GthaGxsZkBAAA67&Z=1368391952)
   
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://lists.nottingham.ac.uk/pipermail/affymetrix-arabidopsis/attachments/20220413/ff50e9e2/attachment-0001.html>